Efficacy of molnupiravir and nirmatrelvir / ritonavir in reducing hospitalization and deaths in non-hospitalized COVID-19 patients
In a recent study published in Preprints with The Lancet *, researchers evaluated the effectiveness of two orally administered antiviral drugs, nirmatrelvir / ritonavir and molnupiravir, to reduce hospitalization and deaths among the world’s outpatient coronavirus disease. real 2019 (COVID-19) patients in Hong Kong. Study: Impact of the use of oral antiviral agents on the …